Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 63Unknown 21Recruiting 15Terminated 11Active not recruiting 7Not yet recruiting 4Withdrawn 3Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Radiation Injuries 1Oropharyngeal Neoplasms 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Breast Neoplasms 1Adenocarcinoma of Lung 1

Interventions

vactosertib 1fludarabine phosphate 1aldesleukin 1Radiotherapy 1Radiofrequency Ablation 1Paclitaxel 1Interleukin-2 1Injections 1IL32 protein, human 1Endoscopic Mucosal Resection 1Cyclophosphamide 1Carboplatin 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Esophageal Neoplasms × Radiotherapy × Clear all
NCT05191667 2025-02-13

AN0025 and Chemoradiotherapy Combination in Esophageal Cancer

Adlai Nortye Biopharma Co., Ltd.

Phase 1 Suspended
32 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡